Is it appropriate to prescribe a cephalosporin antibiotic to a patient with infectious mononucleosis?

Can You Give a Cephalosporin When Someone Has Mono?

Yes, cephalosporins can be safely prescribed to patients with infectious mononucleosis (IM), though they carry a risk of rash that is lower than with aminopenicillins but still elevated compared to no antibiotic use.

The Rash Risk: What the Evidence Shows

The classic teaching that aminopenicillins (like amoxicillin) cause rash in nearly all patients with mono is outdated. Recent evidence demonstrates that only 18% of IM patients develop rash after aminopenicillin exposure, not the 80-90% reported in older studies from the 1960s-70s 1. This is a critical update to conventional wisdom.

For cephalosporins specifically:

• 15% of IM patients develop rash after cephalosporin use 1
• This compares to 14% rash rate with no antibiotic use 1
• The risk is significantly lower than the 43% overall rate with aminopenicillins 1

Clinical Decision-Making

When Antibiotics Are Indicated in IM

Most patients with IM do not require antibiotics, as it's a viral illness. However, antibiotics become necessary when:

• Secondary bacterial pharyngitis is suspected (though distinguishing this clinically from viral pharyngitis alone is challenging)
• Documented bacterial superinfection occurs
• The patient was empirically treated before IM diagnosis was confirmed (which occurs in 82.6% of hospitalized IM cases) 2

Choosing Among Antibiotics

If antibiotics are truly indicated for a bacterial infection in a patient with IM:

Cephalosporins are a reasonable choice and should not be categorically avoided. The data shows:

• No significant difference in rash risk between amoxicillin, other penicillins, cephalosporins, or macrolides in IM patients 3
• Cefuroxime was the second most commonly prescribed antibiotic (27.7%) in one large series of IM patients 2
• Case reports document cephalexin-associated rash in IM 4, but this appears uncommon

Important Caveats

The Rash Itself

• Any rash that develops is typically benign and self-limited, resolving within 10 days 5
• The rash is usually maculopapular, not a true allergic reaction
• However, some patients may develop persistent drug allergy that can last years 6, making allergy testing important if rash occurs

The Real Clinical Problem

The bigger issue is unnecessary antibiotic use in IM patients. In one series, 82.6% of hospitalized IM patients received prehospital antibiotics, with amoxicillin/clavulanate (46.2%) and cefuroxime (27.7%) being most common 2. This represents substantial antibiotic overuse, as most IM cases are purely viral.

Practical Approach

1. Confirm the need for antibiotics first - Most IM patients don't need them
2. If bacterial infection is documented or highly suspected, choose based on the specific infection:
   • Cephalosporins are appropriate choices
   • Don't avoid them solely due to IM diagnosis
3. Counsel patients that a rash may develop (15% risk) but is usually benign
4. If rash occurs, consider allergy testing later to determine if true drug allergy developed 6
5. Monitor for severe reactions (though these are rare)

The outdated dogma of near-universal rash with beta-lactams in IM should not drive antibiotic selection when antibiotics are genuinely indicated. The more important clinical decision is whether antibiotics are needed at all.